IBEX Wealth Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-26,039
Closed -$4.91M 220
2024
Q3
$4.91M Buy
26,039
+25,231
+3,123% +$1.88M 1.34% 29
2024
Q2
$56.7K Buy
+808
New +$57.7K 0.01% 157
2024
Q1
Sell
-4,000
Closed -$265K 137
2023
Q4
$265K Sell
4,000
-1,450
-27% -$90.7K 0.06% 100
2023
Q3
$343K Buy
+5,450
New +$339K 0.09% 94
2021
Q4
Sell
-725
Closed -$45K 333
2021
Q3
$45K Buy
+725
New +$43.6K 0.01% 279
2019
Q3
Sell
-1,100
Closed -$54K 265
2019
Q2
$54K Buy
+1,100
New +$51.7K 0.02% 213
2018
Q1
Sell
-69,320
Closed -$3.6M 106
2017
Q4
$3.6M Buy
+69,320
New +$3.65M 1.6% 27
2017
Q1
Sell
-312
Closed -$15K 254
2016
Q4
$15K Buy
+312
New +$14.3K 0.01% 250

Other funds holding MET

IBEX Wealth Advisors's MET Position: Q4 2024 in Review

IBEX Wealth Advisors sold out of MetLife (MET) in Q4 2024, closing a stake of 26,039 shares — an estimated $4.91M sold.

IBEX Wealth Advisors first reported a position in MET in Q4 2016 and held it in 8 quarters. The position peaked at $4.91M in Q3 2024. 1,405 funds tracked by Wall St. Rank hold MET as of Q4 2024.

  • IBEX Wealth Advisors reported no remaining MetLife position as of Q4 2024 after selling out during the quarter.
  • IBEX Wealth Advisors sold 26,039 MetLife shares in Q4 2024, an estimated $4.91M.
  • IBEX Wealth Advisors first reported a position in MetLife in Q4 2016 and held it in 8 quarters.
  • IBEX Wealth Advisors's MetLife position peaked at $4.91M in Q3 2024.
  • 1,405 funds tracked by Wall St. Rank held MetLife as of Q4 2024.

Based on IBEX Wealth Advisors's 13F filing for Q4 2024, filed 23 Jan 2025.